These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 6202576)

  • 1. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR; Moriarty RJ; Mayer JH
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH; Tomlinson DR
    Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR; Hawthorne JN; Tomlinson DR
    Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of sorbinil on axonal transport in streptozotocin-diabetic rats.
    Willars GB; Tomlinson DR; Robinson JP
    Metabolism; 1986 Apr; 35(4 Suppl 1):66-70. PubMed ID: 2421136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH; Ross IS
    Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
    Stevens MJ; Lattimer SA; Kamijo M; Van Huysen C; Sima AA; Greene DA
    Diabetologia; 1993 Jul; 36(7):608-14. PubMed ID: 8359577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes.
    Lowitt S; Malone JI; Salem AF; Korthals J; Benford S
    Metabolism; 1995 May; 44(5):677-80. PubMed ID: 7752919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Yorek MA
    Int J Exp Diabetes Res; 2002; 3(1):21-36. PubMed ID: 11900277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine.
    Malone JI; Lowitt S; Corsico N; Orfalian Z
    Int J Clin Pharmacol Res; 1992; 12(5-6):237-41. PubMed ID: 1301404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol.
    Tomlinson DR; Mayer JH
    Exp Neurol; 1985 Aug; 89(2):420-7. PubMed ID: 2410289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a new aldose reductase inhibitor, 8'-chloro-2',3'-dihydrospiro [pyrrolidine-3,6'(5'H)-pyrrolo[1,2,3-de] [1,4]benzoxazine]-2,5,5'- trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats.
    Hirata Y; Fujimori S; Okada K
    Metabolism; 1988 Feb; 37(2):159-63. PubMed ID: 2828821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats.
    Yue DK; Hanwell MA; Satchell PM; Turtle JR
    Diabetes; 1982 Sep; 31(9):789-94. PubMed ID: 6819173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorbitol, inositol and nerve conduction in diabetes.
    Gillon KR; Hawthorne JN
    Life Sci; 1983 Apr; 32(17):1943-7. PubMed ID: 6835015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats.
    Tomlinson DR; Robinson JP; Compton AM; Keen P
    Diabetologia; 1989 Sep; 32(9):655-9. PubMed ID: 2477293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity.
    Greene DA; Lattimer SA
    Diabetes; 1984 Aug; 33(8):712-6. PubMed ID: 6086432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat.
    Cameron NE; Leonard MB; Ross IS; Whiting PH
    Diabetologia; 1986 Mar; 29(3):168-74. PubMed ID: 3084324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effects of aldose reductase inhibition.
    Willars GB; Calcutt NA; Compton AM; Tomlinson DR; Keen P
    J Neurol Sci; 1989 Jun; 91(1-2):153-64. PubMed ID: 2473171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of defects of axonal transport in experimental diabetes by aldose reductase inhibitors.
    Tomlinson DR; Willars GB; Robinson JP
    Drugs; 1986; 32 Suppl 2():15-8. PubMed ID: 2431858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2',5'-dioxospiro-[chroman-4,4'-imidazolidine]-2-carbox amide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats.
    Kato N; Mizuno K; Matsubara A; Nakano K; Kurono M; Yagihashi S
    J Diabetes Complications; 1994; 8(1):27-32. PubMed ID: 8167384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.